Researcher Next
Create account
← Back to directory

Mike Sathekge

Researcher Next ID · RN-043181

Researcher · Medicine

Steve Biko Hospital

Pretoria, South Africa

Sign in to saveSign in to claim
Accepting doctoral researchersFunding unknown
Works count
457
Citation count
8,792
H-index
49
i10-index
169

Research interests

Medicine
Radiopharmaceutical Chemistry and Applications
Prostate Cancer Treatment and Research
Medical Imaging Techniques and Applications
Infectious Diseases and Tuberculosis
Prostate Cancer Diagnosis and Treatment

Publications

  • Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study

    The Lancet Oncology · 2024 · 10.1016/s1470-2045(23)00638-1

  • 68Ga-FAPI-PET/CT in patients with various gynecological malignancies

    European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 10.1007/s00259-021-05378-0

  • Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

    European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 10.1007/s00259-021-05307-1

  • Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225 Ac-PSMA-617 Radioligand Therapy

    Journal of Nuclear Medicine · 2019 · 10.2967/jnumed.119.229229

  • 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

    European Journal of Nuclear Medicine and Molecular Imaging · 2018 · https://doi.org/10.1007/s00259-018-4167-0

  • An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

    Current Radiopharmaceuticals · 2018 · https://doi.org/10.2174/1874471011666180502104524

  • Intraindividual Comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study

    Journal of Nuclear Medicine · 2017 · 10.2967/jnumed.117.204669

  • 213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer

    European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 10.1007/s00259-017-3657-9

  • Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging

    BioMed Research International · 2014 · 10.1155/2014/867381

  • Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours

    European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 10.1007/s00259-012-2280-z

Current projects

    No projects listed.